Association between Body Mass Index and Response to Duloxetine for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in SWOG S1202

BACKGROUND: Aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) negatively impact adherence and persistence with therapy. In SWOG S1202, patients with AIMSS treated with duloxetine, a serotonin norepinephrine reuptake inhibitor, reported improvement in pain by 12 weeks compared to p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Henry, N. Lynn, Unger, Joseph M., Till, Cathee, Schott, Anne F., Crew, Katherine D., Lew, Danika L., Fisch, Michael J., Moinpour, Carol M., Wade, James L., Hershman, Dawn L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6675412/
https://ncbi.nlm.nih.gov/pubmed/30861098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32024
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky